Transcatheter Closure of Patent Foramen Ovale in Patients With Peripheral (Noncerebrovascular) Embolism

Scarce data exist on noncerebrovascular peripheral embolism (NCPE) patients undergoing transcatheter patent foramen ovale (PFO) closure. The objectives of this study were to determine the clinical and procedural characteristics, and long-term outcomes of patients with NCPE undergoing transcatheter P...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of invasive cardiology 2022-10, Vol.34 (10), p.E720
Main Authors: Farjat-Pasos, Julio I, Guedeney, Paul, Houde, Christine, Alperi, Alberto, Mesnier, Jules, Côté, Melanie, Montalescot, Gilles, Rodés-Cabau, Josep
Format: Article
Language:English
Subjects:
Anticoagulants - therapeutic use
Cardiac Catheterization - methods
Embolism - diagnosis
Embolism - epidemiology
Embolism - etiology
Embolism, Paradoxical - diagnosis
Embolism, Paradoxical - epidemiology
Embolism, Paradoxical - etiology
Follow-Up Studies
Foramen Ovale, Patent - complications
Foramen Ovale, Patent - diagnosis
Foramen Ovale, Patent - surgery
Humans
Stroke - epidemiology
Stroke - etiology
Stroke - prevention & control
Treatment Outcome
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Scarce data exist on noncerebrovascular peripheral embolism (NCPE) patients undergoing transcatheter patent foramen ovale (PFO) closure. The objectives of this study were to determine the clinical and procedural characteristics, and long-term outcomes of patients with NCPE undergoing transcatheter PFO closure. This was a multicenter study including 1136 consecutive patients who underwent PFO closure after a thromboembolic event. Patients were divided into 2 groups according to the type of event leading to PFO closure, ie, cerebrovascular event (CVE, n = 1099 [96.7%]) and NCPE (n = 37 [3.3%]). The median follow-up was 3 years (interquartile range, 1-8), with follow-up complete in 98%. Patients in the NCPE group exhibited higher rates of prior or concomitant pulmonary embolism (29.7% vs 3.4%; P
ISSN:1557-2501
1557-2501
DOI:10.25270/jic/22.00079